Multiple Sclerosis
📧 Sign up to get email alerts when something new happens for Multiple Sclerosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-10-11Clinical Trial Update: Effect of Photobiomodulation Treatment in Individuals With Multiple Sclerosis: [Phase 2]
A Phase 2 clinical trial evaluating photobiomodulation treatment in individuals with Multiple Sclerosis; current status is unknown.
-
CLINICAL_TRIALS trial_result · 2018-09-19Clinical Trial Update: Safety and Efficacy of Fingolimod in Pediatric Patients With Multiple Sclerosis [Phase 3]
This clinical trial update reports safety and efficacy data for fingolimod in pediatric patients with multiple sclerosis from a Phase 3 stud…
-
CLINICAL_TRIALS trial_result · 2018-09-19Clinical Trial Update: Safety and Efficacy of Fingolimod in Pediatric Patients With Multiple Sclerosis [Phase 3]
Phase 3 trial assessing safety and efficacy of fingolimod in pediatric multiple sclerosis patients.
-
CLINICAL_TRIALS trial_result · 2018-09-17Clinical Trial Update: The Immunomodulatory Effects of Oral Nanocurcumin in Multiple Sclerosis Patients [Phase 2]
Phase 2 clinical trial assessing oral nanocurcumin's immunomodulatory effects in multiple sclerosis patients has been completed.
-
FDA approval · 2018-09-07FDA Approved: COPAXONE — Supplemental Application (Teva Neuroscience, Inc.)
The FDA approved a supplemental application for Copaxone (glatiramer acetate) from Teva Neuroscience, Inc., indicating an update to the prod…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2018-09-04FDA Approved: TERIFLUNOMIDE — Original Application (Teva Pharmaceuticals, Inc.)
FDA approved Teva's original application for a generic teriflunomide, expanding access to this disease-modifying therapy for multiple sclero…
-
FDA approval · 2018-08-31FDA Approved: BETASERON — Supplemental Application (Bayer HealthCare Pharmaceuticals Inc.)
The FDA approved Bayer's supplemental application for Betaseron (interferon beta-1b), updating the product labeling.
-
CLINICAL_TRIALS trial_result · 2018-08-23Clinical Trial Update: Resistance Training and Amino Pyridine in Multiple Sclerosis [Phase 4]
Phase 4 clinical trial update on resistance training and Amino Pyridine for Multiple Sclerosis has completed.
-
CLINICAL_TRIALS trial_result · 2018-08-23Clinical Trial Update: FAME - Fampyra Outcome Measures Study: a Study of Different Outcome Measures on the Effect of Fampyra [Phase 4]
Phase 4 trial update evaluating different outcome measures for the effect of Fampyra in multiple sclerosis; study completed.
-
CLINICAL_TRIALS trial_result · 2018-08-20Clinical Trial Update: Study to Assess Medication Satisfaction in Patients With Relapsing Remitting Multiple Sclerosis Treated With Copaxone® [Phase 4]
Phase 4 trial updating medication satisfaction in relapsing multiple sclerosis patients treated with Copaxone.
-
FDA approval · 2018-07-30FDA Approved: DALFAMPRIDINE — Original Application (Ascend Laboratories, LLC)
FDA approval for the original ANDA of dalfampridine from Ascend Laboratories, LLC.
-
CLINICAL_TRIALS trial_result · 2018-07-24Clinical Trial Update: Study of Montelukast on Gastrointestinal Tolerability in Patients With Relapsing Forms of Multiple Sclerosis Receiving Tecfidera [Phase 4]
Phase 4 trial evaluating montelukast for gastrointestinal tolerability in patients with relapsing forms of multiple sclerosis treated with T…
-
CLINICAL_TRIALS research · 2018-07-19Clinical Trial Update: Characterization of White Blood Cells Sub-populations From Multiple Sclerosis Patients.
This clinical trial update describes an investigation into white blood cell subpopulations in patients with multiple sclerosis.
-
CLINICAL_TRIALS withdrawal · 2018-07-18Clinical Trial Update: The Effects of Different Medical Marijuana Strains on Motor and Cognitive Function in People With Multiple Sclerosis [Phase 2, Phase 3]
A clinical trial evaluating the effects of different medical marijuana strains on motor and cognitive function in people with Multiple Scler…
-
CLINICAL_TRIALS research · 2018-07-17Clinical Trial Update: The Reliability, Validity, and Responsiveness of the Static Balance Test in Patients With Multiple Sclerosis.
This clinical trial update evaluates the reliability, validity, and responsiveness of the Static Balance Test in patients with Multiple Scle…
-
CLINICAL_TRIALS trial_result · 2018-07-17Clinical Trial Update: A Cognitive Self-Management Intervention for Persons With Multiple Sclerosis: Adapting Web-based Technology [NA]
This entry reports the completion of a clinical trial evaluating a web-based cognitive self-management intervention for people with Multiple…
-
CLINICAL_TRIALS research · 2018-07-13Clinical Trial Update: " Treating MS Patients With Lower Extremity Spasticity Using Dysport" [Phase 3]
Phase 3 clinical trial update evaluating Dysport (abobotulinumtoxinA) for lower extremity spasticity in multiple sclerosis patients.
-
CLINICAL_TRIALS trial_result · 2018-07-11Clinical Trial Update: Betaferon Use in Children and Adolescents With Multiple Sclerosis
This clinical trial update reports the completion of a Bayer-sponsored study evaluating Betaferon (interferon beta-1b) in children and adole…
-
FDA approval · 2018-07-11FDA Approved: DALFAMPRIDINE — Original Application (Accord Healthcare Inc.)
FDA approved the original application for dalfampridine as a generic (Accord Healthcare Inc.), marking the approval of a generic dalfampridi…
-
EMA withdrawal · 2018-06-28EMA Withdrawn: Zinbryta (daclizumab) — Biogen Idec Ltd
The EMA has withdrawn Zinbryta (daclizumab) from the market for multiple sclerosis.
-
CLINICAL_TRIALS trial_result · 2018-06-28Clinical Trial Update: Multiple Sclerosis and Pilates [NA]
A clinical trial evaluating Pilates as an intervention for people with Multiple Sclerosis has completed.
-
CLINICAL_TRIALS trial_result · 2018-06-26Clinical Trial Update: Nutrition, Neuromuscular Electrical Stimulation (NMES) and Secondary Progressive Multiple Sclerosis (SPMS) [Phase 1]
A Phase 1 clinical trial sponsored by the University of Iowa evaluating nutrition and neuromuscular electrical stimulation in Secondary Prog…
-
CLINICAL_TRIALS trial_result · 2018-06-26Clinical Trial Update: Wahls Paleo Diet and Progressive Multiple Sclerosis [NA]
This document notes the completion of a clinical trial evaluating the Wahls Paleo Diet in individuals with progressive multiple sclerosis.
-
CLINICAL_TRIALS trial_result · 2018-06-26Clinical Trial Update: Preventing Falls and Participation Restrictions in Neurological Diseases [NA]
A clinical trial update notes that a study on preventing falls and participation restrictions in neurological diseases has completed. The co…
-
CLINICAL_TRIALS trial_result · 2018-06-21Clinical Trial Update: Study of Betaferon Adherence in Patients With Multiple Sclerosis Treated With Interferon Beta-1b
A completed clinical trial update on adherence to Betaferon (interferon beta-1b) in people with multiple sclerosis.